Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.

Juilland M, Thome M.

Curr Opin Hematol. 2016 Jul;23(4):402-9. doi: 10.1097/MOH.0000000000000257.

2.

API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.

Rosebeck S, Lim MS, Elenitoba-Johnson KS, McAllister-Lucas LM, Lucas PC.

World J Biol Chem. 2016 Feb 26;7(1):128-37. doi: 10.4331/wjbc.v7.i1.128. Review.

3.

The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling.

Klein T, Fung SY, Renner F, Blank MA, Dufour A, Kang S, Bolger-Munro M, Scurll JM, Priatel JJ, Schweigler P, Melkko S, Gold MR, Viner RI, Régnier CH, Turvey SE, Overall CM.

Nat Commun. 2015 Nov 3;6:8777. doi: 10.1038/ncomms9777.

4.

The paracaspase MALT1: biological function and potential for therapeutic inhibition.

Jaworski M, Thome M.

Cell Mol Life Sci. 2016 Feb;73(3):459-73. doi: 10.1007/s00018-015-2059-z. Epub 2015 Oct 27. Review.

5.

The Paracaspase MALT1.

Hachmann J, Salvesen GS.

Biochimie. 2016 Mar;122:324-38. doi: 10.1016/j.biochi.2015.09.018. Epub 2015 Sep 16. Review.

PMID:
26386283
6.

Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.

Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T.

World J Gastroenterol. 2015 Jul 14;21(26):8014-20. doi: 10.3748/wjg.v21.i26.8014. Review.

7.

MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.

Pan D, Jiang C, Ma Z, Blonska M, You MJ, Lin X.

Oncogene. 2016 Feb 18;35(7):919-28. doi: 10.1038/onc.2015.146. Epub 2015 May 18.

8.

Probes to monitor activity of the paracaspase MALT1.

Hachmann J, Edgington-Mitchell LE, Poreba M, Sanman LE, Drag M, Bogyo M, Salvesen GS.

Chem Biol. 2015 Jan 22;22(1):139-47. doi: 10.1016/j.chembiol.2014.11.011. Epub 2014 Dec 31.

9.

MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.

Baens M, Bonsignore L, Somers R, Vanderheydt C, Weeks SD, Gunnarsson J, Nilsson E, Roth RG, Thome M, Marynen P.

PLoS One. 2014 Aug 8;9(8):e103774. doi: 10.1371/journal.pone.0103774. eCollection 2014.

10.

Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.

Mc Guire C, Elton L, Wieghofer P, Staal J, Voet S, Demeyer A, Nagel D, Krappmann D, Prinz M, Beyaert R, van Loo G.

J Neuroinflammation. 2014 Jul 21;11:124. doi: 10.1186/1742-2094-11-124.

11.

Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Pereira MI, Medeiros JA.

World J Gastroenterol. 2014 Jan 21;20(3):684-98. doi: 10.3748/wjg.v20.i3.684. Review.

12.

NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.

Uno M, Saitoh Y, Mochida K, Tsuruyama E, Kiyono T, Imoto I, Inazawa J, Yuasa Y, Kubota T, Yamaoka S.

PLoS One. 2014 Feb 12;9(2):e88347. doi: 10.1371/journal.pone.0088347. eCollection 2014.

13.

The CBM signalosome: potential therapeutic target for aggressive lymphoma?

Yang C, David L, Qiao Q, Damko E, Wu H.

Cytokine Growth Factor Rev. 2014 Apr;25(2):175-83. doi: 10.1016/j.cytogfr.2013.12.008. Epub 2013 Dec 24. Review.

14.

IAP proteins as targets for drug development in oncology.

Dubrez L, Berthelet J, Glorian V.

Onco Targets Ther. 2013 Sep 16;9:1285-304. doi: 10.2147/OTT.S33375. Review.

15.

IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.

Oberoi-Khanuja TK, Murali A, Rajalingam K.

Cell Death Dis. 2013 Sep 5;4:e784. doi: 10.1038/cddis.2013.311. Review.

16.

Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.

Cabalzar K, Pelzer C, Wolf A, Lenz G, Iwaszkiewicz J, Zoete V, Hailfinger S, Thome M.

PLoS One. 2013 Aug 19;8(8):e72051. doi: 10.1371/journal.pone.0072051. eCollection 2013.

17.

The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-κB signaling.

Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O'Donnell MA, Ting AT, Du MQ, Baens M, Lucas PC, McAllister-Lucas LM.

Oncogene. 2014 May 8;33(19):2520-30. doi: 10.1038/onc.2013.195. Epub 2013 Jun 17.

18.

Gastrointestinal B-cell lymphomas: From understanding B-cell physiology to classification and molecular pathology.

Sagaert X, Tousseyn T, Yantiss RK.

World J Gastrointest Oncol. 2012 Dec 15;4(12):238-49. doi: 10.4251/wjgo.v4.i12.238.

19.

BCL10GFP fusion protein as a substrate for analysis of determinants required for mucosa-associated lymphoid tissue 1 (MALT1)-mediated cleavage.

Jou SY, Chang CC, Wu CH, Chen MR, Tsai CH, Chuang WH, Chen YH, Cheng AL, Doong SL.

J Biomed Sci. 2012 Oct 5;19:85. doi: 10.1186/1423-0127-19-85.

20.

Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation.

Liu J, Sudom A, Min X, Cao Z, Gao X, Ayres M, Lee F, Cao P, Johnstone S, Plotnikova O, Walker N, Chen G, Wang Z.

J Biol Chem. 2012 Aug 10;287(33):27326-34. doi: 10.1074/jbc.M112.366658. Epub 2012 Jun 20.

Items per page

Supplemental Content

Write to the Help Desk